Harmony Biosciences Holdings (HRMY) Debt Ratio (2019 - 2026)

Harmony Biosciences Holdings' Debt Ratio history runs 8 years deep, the most recent figure standing at 0.12 for Q1 2026.

• In Q1 2026, Debt Ratio fell 24.97% year-over-year to 0.12; the TTM figure through Mar 2026 stood at 0.12 (down 24.97% YoY), while the FY2025 annual figure was 0.13, down 28.26% from the prior year.
• Debt Ratio came in at 0.12 for Q1 2026 at Harmony Biosciences Holdings, down from 0.13 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.41 in Q1 2022 to a low of 0.12 in Q1 2026.
• A 5-year average of 0.23 and a median of 0.22 in 2024 frame the typical range for Debt Ratio.
• Across the five-year window, Debt Ratio sank 39.33% in 2022 and retreated 13.78% in 2024, its largest moves.
• Harmony Biosciences Holdings' Debt Ratio stood at 0.28 in 2022, then fell by 16.12% to 0.24 in 2023, then retreated by 24.79% to 0.18 in 2024, then declined by 28.26% to 0.13 in 2025, then decreased by 2.98% to 0.12 in 2026.
• According to Business Quant data, Debt Ratio over the past three periods registered 0.12, 0.13, and 0.14 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison